• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种富集原发性卵巢癌细胞的新技术。

A novel technique for the enrichment of primary ovarian cancer cells.

作者信息

Chan John K, Hamilton Chad A, Anderson Ellen M, Cheung Michael K, Baker Jeanette, Husain Amreen, Teng Nelson N, Kong Christina S, Negrin Robert S

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, San Francisco, UCSF Comprehensive Cancer Center, 94143-1702, USA.

出版信息

Am J Obstet Gynecol. 2007 Nov;197(5):507.e1-5. doi: 10.1016/j.ajog.2007.05.006.

DOI:10.1016/j.ajog.2007.05.006
PMID:17980191
Abstract

OBJECTIVE

Primary cancer cells that are extracted from ovarian tumors can serve as an optimal substrate to study the biologic characteristics of ovarian cancer. We describe an efficient and effective method of enriching ovarian tumor cells from ascitic fluid using an immunomagnetic-based method.

STUDY DESIGN

Mononuclear cells were isolated from ascites specimens by Ficoll gradient separation. Epithelial ovarian cancer cells were labeled magnetically with monoclonal human epithelial antigen-125 that is conjugated to microbeads. After immunomagnetic separation, the purity of tumor cells before and after purification was quantified by cytologic analysis and confirmed by fluorescence-activated cell sorter analysis.

RESULTS

Peritoneal ascites specimens were obtained from 6 patients with ovarian cancer. The median age of our patients was 61.5 years (range, 46-79 years). Three patients had papillary serous carcinoma; 2 patients had clear cell carcinoma, and 1 patient had an undifferentiated adenocarcinoma. The mean tumor purity was only 22.8% +/- 10% (range, 1%-60%) before separation. After enrichment, the purity improved to 82.3% +/- 4.0% (range, 70%-90%). Our enrichment technique increased the tumor purity by 59.5% +/- 8.4%. The mean percent yield after positive enrichment was 30.1% +/- 14.5%.

CONCLUSION

The immunomagnetic cell separation technique is an efficient and effective method for isolating and purifying ovarian tumor cells from ascites. Results from experiments with fresh tumor cells rather than cancer cell lines may be more relevant for clinical application.

摘要

目的

从卵巢肿瘤中提取的原发性癌细胞可作为研究卵巢癌生物学特性的理想底物。我们描述了一种基于免疫磁珠法从腹水中富集卵巢肿瘤细胞的高效方法。

研究设计

通过Ficoll梯度分离法从腹水标本中分离出单核细胞。用与微珠偶联的单克隆人上皮抗原-125对上皮性卵巢癌细胞进行磁性标记。免疫磁珠分离后,通过细胞学分析对纯化前后肿瘤细胞的纯度进行定量,并通过荧光激活细胞分选分析进行确认。

结果

从6例卵巢癌患者中获取腹水标本。患者的中位年龄为61.5岁(范围46 - 79岁)。3例为乳头状浆液性癌;2例为透明细胞癌,1例为未分化腺癌。分离前肿瘤细胞的平均纯度仅为22.8%±10%(范围1% - 60%)。富集后,纯度提高到82.3%±4.0%(范围70% - 90%)。我们的富集技术使肿瘤纯度提高了59.5%±8.4%。阳性富集后的平均回收率为30.1%±14.5%。

结论

免疫磁珠细胞分离技术是一种从腹水中分离和纯化卵巢肿瘤细胞的高效方法。使用新鲜肿瘤细胞而非癌细胞系进行实验的结果可能对临床应用更具相关性。

相似文献

1
A novel technique for the enrichment of primary ovarian cancer cells.一种富集原发性卵巢癌细胞的新技术。
Am J Obstet Gynecol. 2007 Nov;197(5):507.e1-5. doi: 10.1016/j.ajog.2007.05.006.
2
An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites.一种基于免疫磁珠的从患者腹水中纯化卵巢癌细胞的方法。
Gynecol Oncol. 2001 Jul;82(1):57-63. doi: 10.1006/gyno.2001.6226.
3
Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.具有乳头状特征的卵巢透明细胞癌:一种可能被误诊为低恶性潜能浆液性肿瘤的疾病。
Am J Surg Pathol. 2008 Feb;32(2):269-74. doi: 10.1097/PAS.0b013e31814fa9b0.
4
A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases.一种用于检测和鉴定乳腺癌患者骨髓中上皮细胞粘附分子阳性细胞的相关免疫磁珠分析:微转移灶的免疫磁珠纯化
Cancer. 2004 Aug 15;101(4):693-703. doi: 10.1002/cncr.20391.
5
Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads.使用免疫磁珠检测胃癌患者腹腔灌洗液中的端粒酶活性。
Br J Cancer. 2000 Oct;83(8):1026-32. doi: 10.1054/bjoc.2000.1408.
6
[Detection of tumor cells in peripheral blood for patients with ovarian epithelial carcinoma].[卵巢上皮癌患者外周血中肿瘤细胞的检测]
Zhonghua Fu Chan Ke Za Zhi. 1999 May;34(5):301-3.
7
Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro.在体外,免疫磁珠细胞富集法比免疫细胞化学法能检测到更多的播散癌细胞。
J Urol. 2000 Nov;164(5):1834-7.
8
An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.一种用于检测细胞角蛋白8+恶性肿瘤微小残留病的免疫磁上皮肿瘤细胞富集模型。
J Biol Regul Homeost Agents. 2005 Jan-Jun;19(1-2):84-91.
9
[Detecting bone marrow micrometastasis of gastric cancer by magnetic activated cell sorting combined with fluorescent activated cell sorting].磁性激活细胞分选联合荧光激活细胞分选检测胃癌骨髓微转移
Ai Zheng. 2005 May;24(5):605-10.
10
Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms.浆液性交界性肿瘤中的鞋钉样细胞并不代表同时存在的早期透明细胞肿瘤。
Hum Pathol. 2009 Aug;40(8):1168-75. doi: 10.1016/j.humpath.2009.01.002. Epub 2009 Apr 14.

引用本文的文献

1
Detection of carcinoma in serous effusions: a review.浆液性积液中癌的检测:综述
Am J Cancer Res. 2021 Jan 1;11(1):43-60. eCollection 2021.
2
Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805.新型抗叶酸受体α抗体KHK2805对腹膜播散和恶性腹水具有强大的治疗活性。
Transl Oncol. 2017 Oct;10(5):707-718. doi: 10.1016/j.tranon.2017.06.007. Epub 2017 Jul 12.
3
Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART).
通过一种新型无细胞浓缩腹水再输注疗法(KM-CART)从患者灌洗液中有效回收高度纯化的CD326(+)肿瘤细胞。
Springerplus. 2015 Dec 17;4:780. doi: 10.1186/s40064-015-1508-3. eCollection 2015.
4
Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.铂敏感和耐药性高级别浆液性卵巢癌建模:实验系统的开发与应用
Front Oncol. 2014 Apr 17;4:81. doi: 10.3389/fonc.2014.00081. eCollection 2014.
5
Molecular-targeted therapies for ovarian cancer: prospects for the future.卵巢癌的分子靶向治疗:未来展望。
Int J Clin Oncol. 2012 Oct;17(5):424-9. doi: 10.1007/s10147-012-0461-1. Epub 2012 Aug 23.
6
Dielectrophoretic differentiation of mouse ovarian surface epithelial cells, macrophages, and fibroblasts using contactless dielectrophoresis.采用无接触式介电泳法对小鼠卵巢表面上皮细胞、巨噬细胞和成纤维细胞进行介电泳分化。
Biomicrofluidics. 2012 Jun;6(2):24104-2410413. doi: 10.1063/1.3699973. Epub 2012 Apr 3.
7
Beyond chemotherapy: targeted therapies in ovarian cancer.超越化疗:卵巢癌的靶向治疗
Nat Rev Cancer. 2009 Mar;9(3):167-81. doi: 10.1038/nrc2583.